Prempro Breast Cancer Lawsuit Results in $72M Verdict

|
Staff Writers

Add Your Comments

A Philadelphia jury has hit Pfizer with a $72.6 million verdict in a Prempro lawsuit brought by three women who alleged that they developed breast cancer after taking hormone replacement therapy (HRT) drugs. In addition to the compensatory damages award, the drug maker could face punitive damages of many times that amount depending on the further deliberations of the jury. 

The verdict was handed down on Tuesday in a Prempro breast cancer lawsuit fled by Susan Elfont, Bernadette Kalenkoski and Judy Mulderig in the Philadelphia Court of Common Pleas.

The jury awarded Elfont $20 million; Kalenkoski, $27.85 million; and Mulderig, $24.75 million in compensatory damages. However, the jury still has to decide whether Pfizer should pay punitive damages for willfully disregarding or endangering the safety of the women for profit.

Do You Know about…

hair dye cancer lawsuits For Salon Professionals

Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION
Hair-Dye-Cancer-Lawsuits
Hair-Dye-Cancer-Lawsuits

Do You Know About…

hair dye cancer lawsuits For Salon Professionals

Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION

If the jury finds that punitive damages are necessary, such awards are often many times the amount of the compensatory damages. The jury will likely reach a decision within the next two weeks.

Prempro contains a combination of the drugs Provera and Premarin, to artificially boost hormone levels in women undergoing menopause due to surgery or in postmenopausal women.

Known as hormone replacement therapy, or HRT, the drugs are designed to provide relief from symptoms such as hot flashes, irregular menstruation or weight gain.

About 10,000 Prempro lawsuits have been filed against Pfizer’s subsidiaries, all involving similar allegations that the drug makers failed to adequately research the side effects of Prempro or warn that the medication may increase the risk of breast cancer.

Most of the complaints were filed after a 2002 study by the National Institutes of Health found that women receiving hormone replacement therapy (HRT) were at a higher risk of breast cancer, strokes and heart attacks. By that time, Prempro and other HRT drugs had been used by more than 6 million women.

In May, Pfizer announced that it was setting aside $772 million to reach settlement on about one-third of those lawsuits.

A number of other Prempro trials have resulted in multi-million dollar compensatory awards against the drug maker and even larger punitive damage awards after juries determined that Wyeth intentionally hid the risk of breast cancer from Prempro.

Tags: Breast Cancer, Cancer, Hormone Replacement Therapy, HRT, Pfizer, Premarin, Prempro, Provera, Wyeth
Image Credit: |

More Lawsuit Stories

1 Comments

  1. Marie

    I contracted breast cancer after taking Prempro from 1991 to 2003. I subsequently was diagnosed with breast cancer and was treated with six weeks of radiation this past June and July of 2011.
    I would like to be included in the case against Pfizer.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement
In the six months since a Bard hernia mesh settlement agreement was reached, at least two dozen new lawsuits have been brought, as the implants continue to fail and require revision surgery.
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials
As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025.
MORE ABOUT: BIOZORB LAWSUIT
Depo-Provera Meningioma Diagnosis Information Required to Qualify For Lawsuit
Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case.